XENETIC BIOSCIENCES, INC.: cashflow_investing
| Value | {"amount": 0, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | XENETIC BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:33:22.790327+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c0cae79c-47c7-49c4-b2f8-550251272d9d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001683168-24-001594Retrieved: 2026-08-19T15:33:22.790327+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001534525/cashflow-investing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c0cae79c-47c7-49c4-b2f8-550251272d9d
History
- no predecessors — first report